The way its worded "in conjunction with the [scoping] study, consideration is being given to potential 50/50 profit sharing arrangements with the incoming party to solely finance all aspects of any operation", I don't think OZM has been in any JV discussions with third parties (although it is possible). What the Quarterly Report says is that OZM has advanced the Scoping Study on the Mulgabbie Project and alongside this, they have given thought about how to finance it. One financing option they have considered is a JV where the third party (incoming party) sole funds the capex and opex, but any profits are shared equally.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
The way its worded "in conjunction with the [scoping] study,...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OZM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.715M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.6¢ | $519 | 14.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 105000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 0.034 |
1 | 1000 | 0.026 |
1 | 200000 | 0.025 |
1 | 50049 | 0.020 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 105000 | 1 |
0.039 | 210319 | 2 |
0.045 | 21000 | 1 |
0.048 | 25000 | 1 |
0.050 | 39083 | 2 |
Last trade - 10.06am 12/11/2024 (20 minute delay) ? |
Featured News
OZM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online